GVI | ISTB | GVI / ISTB | |
Gain YTD | 6.222 | 5.645 | 110% |
Net Assets | 3.76B | 4.59B | 82% |
Total Expense Ratio | 0.20 | 0.06 | 333% |
Turnover | 21.00 | 39.00 | 54% |
Yield | 3.42 | 4.03 | 85% |
Fund Existence | 19 years | 13 years | - |
GVI | ISTB | |
---|---|---|
RSI ODDS (%) | 3 days ago24% | 3 days ago4% |
Stochastic ODDS (%) | 3 days ago40% | 3 days ago16% |
Momentum ODDS (%) | 3 days ago33% | 3 days ago27% |
MACD ODDS (%) | 3 days ago37% | 3 days ago16% |
TrendWeek ODDS (%) | 3 days ago42% | 3 days ago27% |
TrendMonth ODDS (%) | 3 days ago46% | 3 days ago30% |
Advances ODDS (%) | 6 days ago38% | 6 days ago25% |
Declines ODDS (%) | 11 days ago37% | 11 days ago24% |
BollingerBands ODDS (%) | 3 days ago38% | 3 days ago14% |
Aroon ODDS (%) | 3 days ago51% | 3 days ago29% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DBEM | 31.43 | 0.09 | +0.28% |
Xtrackers MSCI Em Mkts Hdg Eq ETF | |||
BMED | 28.00 | 0.08 | +0.27% |
iShares Health Innovation Active ETF | |||
AOM | 47.58 | 0.08 | +0.17% |
iShares Core 40/60 Moderate Allc ETF | |||
NUEM | 36.64 | -0.07 | -0.18% |
Nuveen ESG Emerging Markets Equity ETF | |||
CRMG | 12.05 | -0.32 | -2.59% |
Leverage Shares 2X Long CRM Daily ETF |
A.I.dvisor tells us that ISTB and SM have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ISTB and SM's prices will move in lockstep.
Ticker / NAME | Correlation To ISTB | 1D Price Change % | ||
---|---|---|---|---|
ISTB | 100% | -0.06% | ||
SM - ISTB | 3% Poorly correlated | -1.53% | ||
PTEN - ISTB | 2% Poorly correlated | -1.96% |